FDA posts testing resources, approves drug for ventilated patients
The Food and Drug Administration yesterday released COVID-19 for four more antibody test kits. The results come from the first collaboration between FDA, the National Institute of Health鈥檚 National Cancer Institute, Centers for Disease Control and Prevention and Biomedical Advanced Research and Development Authority. Meanwhile, a from FDA explains for the public the different categories of COVID-19 tests, such as tests for those currently infected versus those with antibodies.
FDA June 3 also approved a new for intubated and ventilated patients in intensive care settings and non-intubated patients prior to or during surgical and other procedures. The drug鈥檚 most common side effects are hypotension, bradycardia and dry mouth.
Related News Articles
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥�
Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥�
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.鈥檚 nomination for secretary of the Department of Health and Human Services. A鈥�
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu鈥�
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers鈥�
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability鈥�